Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lydon

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinomaD Boiarsky, C A Lydon, E S Chambers, et al.
Journal of the National Cancer Institute|September 22, 2020
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer InstituteSara M Tolaney, Christine A Lydon, Tianyu Li, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung CancerLorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancerK Hastings, H A Yu, W Wei, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2017
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine studyArezou A Ghazani, Nelly M Oliver, Joseph P St Pierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2023
Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinomaD Boiarsky, C A Lydon, E S Chambers, et al.
Journal of the National Cancer Institute|September 22, 2020
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer InstituteSara M Tolaney, Christine A Lydon, Tianyu Li, et al.
Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung CancerLorena Ostios-Garcia, Jennifer Faig, Giulia C Leonardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancerK Hastings, H A Yu, W Wei, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 27, 2017
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine studyArezou A Ghazani, Nelly M Oliver, Joseph P St Pierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Pageof 5